We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$11.4B
AUM Growth
+$504M
Cap. Flow
+$402M
Cap. Flow %
3.53%
Top 10 Hldgs %
17.81%
Holding
2,458
New
259
Increased
1,134
Reduced
877
Closed
119
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CX icon
2251
Cemex
CX
$16.1B
$66K ﹤0.01%
16,794
+336
+2% +$1.23K
LYTS icon
2252
LSI Industries
LYTS
$907M
$66K ﹤0.01%
12,550
-108
-0.9% -$459
PNNT
2253
Pennant Park Investment Corp
PNNT
$244M
$66K ﹤0.01%
10,513
-1,658
-14% -$10.6K
WATT icon
2254
Energous
WATT
$103M
$64K ﹤0.01%
32
OCSL icon
2255
Oaktree Specialty Lending
OCSL
$1.13B
$63K ﹤0.01%
4,033
FGP
2256
DELISTED
Ferrellgas Partners, L.P.
FGP
$63K ﹤0.01%
59,140
+125
+0.2% +$107
AVTX icon
2257
Avalo Therapeutics
AVTX
$1.04B
$61K ﹤0.01%
6
-1
-14% -$11.2K
OPCH icon
2258
Option Care Health
OPCH
$3.61B
$60K ﹤0.01%
4,697
+1,750
+59% +$21.5K
CPIX icon
2259
Cumberland Pharmaceuticals
CPIX
$119M
$59K ﹤0.01%
10,000
LAB icon
2260
Standard BioTools
LAB
$309M
$58K ﹤0.01%
12,500
VSTM icon
2261
Verastem
VSTM
$638M
$58K ﹤0.01%
4,001
+500
+14% +$8.12K
BB icon
2262
BlackBerry
BB
$5.26B
$57K ﹤0.01%
10,916
-2,195
-17% -$15.4K
RRD
2263
DELISTED
RR Donnelley & Sons Co.
RRD
$57K ﹤0.01%
+15,137
New +$36K
EOD
2264
Allspring Global Dividend Opportunity Fund
EOD
$287M
$56K ﹤0.01%
+10,342
New +$56.1K
MNKD icon
2265
MannKind Corp
MNKD
$1.23B
$56K ﹤0.01%
44,757
-1,120
-2% -$1.3K
MYOV
2266
DELISTED
Myovant Sciences Ltd.
MYOV
$56K ﹤0.01%
+10,725
New +$79.6K
MDR
2267
DELISTED
McDermott International
MDR
$55K ﹤0.01%
27,201
-4,342
-14% -$26.7K
AHT
2268
Ashford Hospitality Trust
AHT
$20.3M
$54K ﹤0.01%
+16
New +$44.7K
FSM icon
2269
Fortuna Silver Mines
FSM
$3.21B
$54K ﹤0.01%
+17,410
New +$63.5K
AEG icon
2270
Aegon
AEG
$13.9B
$53K ﹤0.01%
13,981
-3,692
-21% -$14.7K
FAT
2271
DELISTED
FAT Brands
FAT
$52K ﹤0.01%
21,104
-622
-3% -$1.24K
PXJ icon
2272
Invesco Oil & Gas Services ETF
PXJ
$64.5M
$52K ﹤0.01%
2,205
+196
+10% +$5.13K
HCR
2273
DELISTED
Hi-Crush Inc. Common Stock
HCR
$52K ﹤0.01%
29,954
+3,433
+13% +$6.59K
ABEV icon
2274
Ambev
ABEV
$43.9B
$50K ﹤0.01%
10,929
+353
+3% +$1.69K
ATHX
2275
DELISTED
Athersys, Inc. Common Stock
ATHX
$50K ﹤0.01%
1,502

Similar funds

Cambridge Investment Research Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Cambridge Investment Research Advisors held 2,458 positions worth $11.4B, up 4.6% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors deployed $402M of net new capital in Q3 2019, opening 259 new positions and adding to 1,134 existing holdings. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $28M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 309,094 shares worth $11.7M.
  • Cambridge Investment Research Advisors added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $23.1M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2019 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $28M.
  • Cambridge Investment Research Advisors fully exited DXC Technology in Q3 2019, selling an estimated $3.71M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $11.4B portfolio in Q3 2019.
  • Cambridge Investment Research Advisors opened 259 new positions and closed 119 in Q3 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 4.6% quarter-over-quarter to $11.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.